2012 Q1/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +65 Cilag AG
8.7
2 -1 Anergis
8.5
3 +2 Siegfried AG
8.4
4 +0 Piramal Healthcare
8.3
5 -3 Lumavita AG
8.1
6 +12 Actelion Ltd.
7.8
7 +1 Medinova AG
7.6
8 +8 Eisai (company)
7.6
9 -6 Max Zeller Söhne AG
7.5
10 -1 Schwabe Pharma AG
7.5
11 -1 Kuros Biosurgery AG
7.4
12 -1 Redbiotec AG
7.4
13 -7 Newron Suisse SA
7.3
14 -1 Pharmakon Ltd.
7.2
15 -3 Neurimmune Therapeutics AG
7.2
16 +65 Biogen Idec International GmbH
7.2
17 -3 Celgene
7.1
18 +52 Neurim Pharmaceuticals S.A.
7.1
19 +29 Altana Pharma
7.0
20 +14 Menarini
7.0
21 +196 Wockhardt
6.9
22 -5 Astellas Pharma
6.8
23 -16 4-Antibody AG
6.7
24 -4 Debiopharm S.A.
6.6
25 -3 Neurotune
6.6
26 +10 Teva Pharma AG
6.6
27 -12 Renovo
6.6
28 -5 Alkermes
6.5
29 +12 Intercytex
6.4
30 -1 MEDA Pharma GmbH
6.4
31 +26 Arpida AG
6.3
32 -1 BioPartners GmbH
6.3
33 -14 Virbac Schweiz AG
6.3
34 -2 Tricom GmbH, Pharma Division
6.3
35 -2 Helvepharm AG
6.3
36 -1 Auris Medical AG
6.2
37 +5 Nycomed International Management GmbH
6.2
38 +1 GKL Biotec AG
6.2
39 -12 Orion Pharma
6.2
40 -14 Aptalis
6.1
41 -1 Sanofi-Aventis
6.1
42 -18 STADA Arzneimittel
6.0
43 -6 OMIDA AG
6.0
44 +5 Dr. Wild & Co. AG
6.0
45 -1 Galapagos NV
5.9
46 -1 Octapharma AG
5.9
47 +0 Lipideon Biotechnology AG
5.9
48 +2 Allergan
5.9
49 +18 Addex Pharmaceuticals
5.8
50 -7 Lundbeck (Schweiz) AG
5.8


Changes in rank are compared to 2011 Q4/Global Life Sciences. Since then, 4 sites entered the survey and 17 sites could not be included in the rankings (1 fewer since last time). Build your own. Report statistics.